Global DNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

According to APO Research, The global DNA Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for DNA Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for DNA Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for DNA Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for DNA Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of DNA Vaccines include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for DNA Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of DNA Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for DNA Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global DNA Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for DNA Vaccines sales, projected growth trends, production technology, application and end-user industry.

DNA Vaccines Segment by Company

Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

DNA Vaccines Segment by Type

Recombinant Protein Vaccine
Gene-Based Vaccine

DNA Vaccines Segment by Application

Human
Animal

DNA Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DNA Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of DNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global DNA Vaccines Market Size, 2020 VS 2024 VS 2031
1.3 Global DNA Vaccines Market Size Estimates and Forecasts (2020-2031)
1.4 Global DNA Vaccines Sales Estimates and Forecasts (2020-2031)
1.5 Global DNA Vaccines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global DNA Vaccines Market Dynamics
2.1 DNA Vaccines Industry Trends
2.2 DNA Vaccines Industry Drivers
2.3 DNA Vaccines Industry Opportunities and Challenges
2.4 DNA Vaccines Industry Restraints
3 DNA Vaccines Market by Manufacturers
3.1 Global DNA Vaccines Revenue by Manufacturers (2020-2025)
3.2 Global DNA Vaccines Sales by Manufacturers (2020-2025)
3.3 Global DNA Vaccines Average Sales Price by Manufacturers (2020-2025)
3.4 Global DNA Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global DNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global DNA Vaccines Manufacturers, Product Type & Application
3.7 Global DNA Vaccines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global DNA Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 DNA Vaccines Players Market Share by Revenue in 2024
3.8.3 2024 DNA Vaccines Tier 1, Tier 2, and Tier 3
4 DNA Vaccines Market by Type
4.1 DNA Vaccines Type Introduction
4.1.1 Recombinant Protein Vaccine
4.1.2 Gene-Based Vaccine
4.2 Global DNA Vaccines Sales by Type
4.2.1 Global DNA Vaccines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global DNA Vaccines Sales by Type (2020-2031)
4.2.3 Global DNA Vaccines Sales Market Share by Type (2020-2031)
4.3 Global DNA Vaccines Revenue by Type
4.3.1 Global DNA Vaccines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global DNA Vaccines Revenue by Type (2020-2031)
4.3.3 Global DNA Vaccines Revenue Market Share by Type (2020-2031)
5 DNA Vaccines Market by Application
5.1 DNA Vaccines Application Introduction
5.1.1 Human
5.1.2 Animal
5.2 Global DNA Vaccines Sales by Application
5.2.1 Global DNA Vaccines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global DNA Vaccines Sales by Application (2020-2031)
5.2.3 Global DNA Vaccines Sales Market Share by Application (2020-2031)
5.3 Global DNA Vaccines Revenue by Application
5.3.1 Global DNA Vaccines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global DNA Vaccines Revenue by Application (2020-2031)
5.3.3 Global DNA Vaccines Revenue Market Share by Application (2020-2031)
6 Global DNA Vaccines Sales by Region
6.1 Global DNA Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global DNA Vaccines Sales by Region (2020-2031)
6.2.1 Global DNA Vaccines Sales by Region (2020-2025)
6.2.2 Global DNA Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America DNA Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America DNA Vaccines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe DNA Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe DNA Vaccines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific DNA Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific DNA Vaccines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa DNA Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa DNA Vaccines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global DNA Vaccines Revenue by Region
7.1 Global DNA Vaccines Revenue by Region
7.1.1 Global DNA Vaccines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global DNA Vaccines Revenue by Region (2020-2025)
7.1.3 Global DNA Vaccines Revenue by Region (2026-2031)
7.1.4 Global DNA Vaccines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America DNA Vaccines Revenue (2020-2031)
7.2.2 North America DNA Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe DNA Vaccines Revenue (2020-2031)
7.3.2 Europe DNA Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific DNA Vaccines Revenue (2020-2031)
7.4.2 Asia-Pacific DNA Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa DNA Vaccines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa DNA Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Merck DNA Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 GSK DNA Vaccines Product Portfolio
8.2.5 GSK Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Sanofi DNA Vaccines Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Zoties
8.4.1 Zoties Comapny Information
8.4.2 Zoties Business Overview
8.4.3 Zoties DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Zoties DNA Vaccines Product Portfolio
8.4.5 Zoties Recent Developments
8.5 Elanco
8.5.1 Elanco Comapny Information
8.5.2 Elanco Business Overview
8.5.3 Elanco DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Elanco DNA Vaccines Product Portfolio
8.5.5 Elanco Recent Developments
8.6 Boehringer-Ingelheim
8.6.1 Boehringer-Ingelheim Comapny Information
8.6.2 Boehringer-Ingelheim Business Overview
8.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
8.6.5 Boehringer-Ingelheim Recent Developments
8.7 Indian Immunologicals
8.7.1 Indian Immunologicals Comapny Information
8.7.2 Indian Immunologicals Business Overview
8.7.3 Indian Immunologicals DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Indian Immunologicals DNA Vaccines Product Portfolio
8.7.5 Indian Immunologicals Recent Developments
8.8 Plumbline Life Sciences
8.8.1 Plumbline Life Sciences Comapny Information
8.8.2 Plumbline Life Sciences Business Overview
8.8.3 Plumbline Life Sciences DNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
8.8.5 Plumbline Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 DNA Vaccines Value Chain Analysis
9.1.1 DNA Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 DNA Vaccines Production Mode & Process
9.2 DNA Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 DNA Vaccines Distributors
9.2.3 DNA Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings